Headquartered in Cremorne, Australia, Rhinomed Limited, founded in 2004, is a global innovator specializing in the research, development, and commercialization of consumer and medical devices. The company's core expertise lies in wearable nasal technologies engineered to improve breathing, enhance sleep quality, promote general health, and aid in disease diagnosis. Their product portfolio features Turbine, designed to optimize breathing for athletes; Mute, assisting users to breathe more freely and reduce snoring; Pronto, a vapor inhaler for enhanced airflow and improved sleep; and Rhinoswab, utilized for nasal swab collection.